HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration.

AbstractOBJECTIVE:
Validation of a novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration (CVVHDF).
DESIGN AND SETTING:
Prospective cohort trial in medicosurgical intensive care units of two university-affiliated teaching institutions.
PATIENTS:
Participants were patients at high risk for bleeding, with renal failure requiring CVVHDF without heparin. Fourteen patients completed the study.
INTERVENTION:
A convection-based citrate anticoagulation CVVHDF regimen using an isotonic replacement fluid containing citrate administered in predilution. A neutralizing solution of calcium chloride and magnesium sulfate was infused at the end of the circuit. Blood flow rate was set and kept at 125 ml/min, and the flow rate of the replacement fluid was initiated at 1250 ml/h and adjusted thereafter according to the monitoring of blood activated coagulation time (ACT), with a target between 180 to 220 s.
MEASUREMENTS AND RESULTS:
The average filter time-life was 44 h. Thrombosis of the proximal portion of the circuit (which was not anticoagulated) was the main reason for technique failure. A mean urea clearance of 21 ml/min was obtained. Electrolytes and acid-base balance were both well maintained. Six percent (16/287) of Ca(i) readings less than 0.3 mmol/l were associated with very high ACT levels (>300 s).
CONCLUSIONS:
This regimen is shown to be safe, efficacious, and convenient. Citrate anticoagulation should be monitored using postfilter ACT and/or ionized calcium with respective targets of 200-250 s or 0.3-0.4 mmol/l.
AuthorsMarc Dorval, François Madore, Sylvie Courteau, Martine Leblanc
JournalIntensive care medicine (Intensive Care Med) Vol. 29 Issue 7 Pg. 1186-9 (Jul 2003) ISSN: 0342-4642 [Print] United States
PMID12761615 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Citrates
Topics
  • Anticoagulants (therapeutic use)
  • Citrates (therapeutic use)
  • Hemofiltration (methods)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: